Tenet Reports Third Quarter 2023 Results; Raises 2023 Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Tenet Healthcare (THC) Tops Q3 EPS by 24c, Offers Guidance
October 30, 2023 4:11 PM EDTTenet Healthcare (NYSE: THC) reported Q3 EPS of $1.44, $0.24 better than the analyst estimate of $1.20. Revenue for the quarter came in at $5.07 billion versus the consensus estimate of $5.02 billion.
GUIDANCE:
Tenet Healthcare sees Q4 2023 EPS of $1.12-$1.74, versus the consensus of $1.75.... More
